Overexpression of RAD51C in non-small cell lung cancer cells increased cisplatin resistance and radiotherapy, and high expression of RAD51C in non-small cell lung cancer tissues was significantly associated with poor prognoses of the patients36. This evidence concerns the gene RAD51C and non-small cell lung carcinoma.